Short-chain Fructooligosaccharides (scFOS) Market Updates

Global Short-chain Fructooligosaccharides (scFOS) Market size was valued at USD 1.98 billion in 2023 and is poised to grow from USD 2.08 billion in 2024 to USD 3.15 billion by 2032, growing at a CAGR of 5.3% during the forecast period (2025-2032). 

The global veterinary healthcare market is highly competitive, with many leading companies vying for dominance in both domestic and international sectors. To strengthen their market presence and increase profitability, business leaders are increasingly turning to strategic collaboration. Major players such as Zoetis, Intervet International B.V., Elanco, Seva, Wirbach, Merck & Co, Inc., Novartis AG and Bayer AG are among the top players. These companies invest heavily in research and development to develop new products and expand their businesses. Focusing on leveraging alliances and expanding their geographic reach that these companies are poised to maintain their stronghold in the dynamic Short-chain Fructooligosaccharides (scFOS)care market. 'Beneo GmbH (Germany) ', 'Ingredion Incorporated (US) ', 'Cooperatie Koninklijke Cosun UA (Royal Cosun) (Netherlands) ', 'New Francisco Biotechnology Corporation (China) ', 'Abbott Nutrition (US) ', 'Galam Group (Israel) ', 'Nature's Velvet (India) ', 'Tereos Group (France) ', 'Microbiome Plus+ (Canada) ', 'Shandong Bailong Chuangyuan Bio-tech Co., Ltd. (China) '

The rising popularity of plant-based diets is significantly driving the growth of the Short-chain Fructooligosaccharides (scFOS) market. As consumers increasingly shift towards plant-based foods for health, sustainability, and ethical reasons, the demand for natural, plant-derived ingredients like scFOS has surged. U.S. retail sales of plant-based foods saw an 11% increase from 2018 to 2019, reaching a market value of $4.5 billion. In 2021, more than 500,000 people signed up for Veganuary's challenge, marking a 25% rise from 2020, which had over 400,000 participants. scFOS, known for its prebiotic properties, is a popular ingredient in plant-based products, enhancing digestive health while offering a clean label solution. Additionally, as consumers seek functional foods that align with their dietary preferences, the use of scFOS in plant-based formulations continues to grow, further expanding its market presence.

Trends in the Short-chain Fructooligosaccharides (scFOS) Industry: The Rise of Personalized Nutrition: The Short-chain Fructooligosaccharides (scFOS) industry is increasingly embracing personalized nutrition as a significant trend. Consumers are seeking tailored health solutions that cater to their specific digestive needs and dietary preferences. This shift is driven by a growing awareness of the unique roles that prebiotics like scFOS play in gut health. Companies are responding by developing customized products that incorporate scFOS, enabling targeted benefits for individual consumers. Additionally, advancements in technology and data analytics are facilitating the formulation of personalized dietary plans that include scFOS, further enhancing its appeal in the health and wellness market.

In 2023, North America is expected to hold the largest share of the global Short-chain Fructooligosaccharides (scFOS) market, accounting for approximately 40%. This dominance is driven by the increasing consumer focus on health and wellness, particularly concerning gut health. For instance, in a survey study seven out of ten Americans (71%) consider their overall health and well-being to be excellent or good, with 68% of individuals aged 45-64 rating their health in this way. Among those in the 45-64 age group, 69% also rate their digestive health as good or excellent, compared to 74% of those aged 65 and older, and 60% of individuals aged 18-44. Notably, one-third of Americans aged 18-44 describe their digestive or gut health as being in fair condition, in contrast to 22% of those aged 65 and older and 24% of individuals aged 45-64. Additionally, many food and beverage manufacturers in North America are innovating with scFOS to enhance product formulations, offering a wide range of functional options that cater to health-conscious consumers. The combination of rising health awareness, innovative product offerings, and a favorable regulatory environment positions North America as a key player in the scFOS market, driving its significant share in 2023.